Header Logo

Connection

CHANGYI CHEN to Immunotherapy, Active

Back to Details
This is a "connection" page, showing publications CHANGYI CHEN has written about Immunotherapy, Active.
CHANGYI CHEN
Connection Strength
0.095
Immunotherapy, Active
  1. Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer. Mol Cancer Ther. 2008 Feb; 7(2):286-96.
    View in: PubMed
    Score: 0.072
  2. Chimeric Trop2 virus-like particles: a potential immunotherapeutic approach against pancreatic cancer. J Immunother. 2011 Apr; 34(3):251-63.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.